Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Portfolio Company Profile: InterLeukin Combinatorial Therapies
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Meet Rose Wang
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Meet Charlie Weatherspoon
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Oncoheroes Biosciences and Super Sam Foundation Walking Together for Pediatric Cancer Heroes
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
The Gregory Foundation for Cancer Research Joins Oncoheroes Biosciences to Defeat Childhood Cancer
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Portfolio Company Profile: Yiviva
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Introducing the Women’s Venture Competition
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Portfolio Company of AIM-HI Accelerator Fund Receives Additional Investment and Recognition
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
